Gaby L. Longsworth, Ph.D. recently published an article for Bloomberg BNA’s Patent Trademark & Copyright Law Daily that discusses the use of Post-Grant Review in challenging biotech and pharma patents. Specifically, Ms. Longsworth highlights the unique advantages of PGR such as, short trial duration, broad classes of validity challenges, and the ability to settle and/or force claim amendments and why PGR is effective.

To read the full article, please see the attached PDF.